These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 18165614)

  • 1. Immuno-PET: a navigator in monoclonal antibody development and applications.
    van Dongen GA; Visser GW; Lub-de Hooge MN; de Vries EG; Perk LR
    Oncologist; 2007 Dec; 12(12):1379-89. PubMed ID: 18165614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-positron emission tomography: shedding light on clinical antibody therapy.
    van Dongen GA; Vosjan MJ
    Cancer Biother Radiopharm; 2010 Aug; 25(4):375-85. PubMed ID: 20707716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The promise of immuno-PET in radioimmunotherapy.
    Verel I; Visser GW; van Dongen GA
    J Nucl Med; 2005 Jan; 46 Suppl 1():164S-71S. PubMed ID: 15653665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immuno-positron emission tomography in cancer models.
    Reddy S; Robinson MK
    Semin Nucl Med; 2010 May; 40(3):182-9. PubMed ID: 20350627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET.
    van Dongen GA; Poot AJ; Vugts DJ
    Tumour Biol; 2012 Jun; 33(3):607-15. PubMed ID: 22270450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 89Zr-immuno-PET for imaging of long circulating drugs and disease targets: why, how and when to be applied?
    Van Dongen GA; Huisman MC; Boellaard R; Harry Hendrikse N; Windhorst AD; Visser GW; Molthoff CF; Vugts DJ
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):18-38. PubMed ID: 25517081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
    Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA
    J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-PET for Clinical Theranostic Approaches.
    Bailly C; Cléry PF; Faivre-Chauvet A; Bourgeois M; Guérard F; Haddad F; Barbet J; Chérel M; Kraeber-Bodéré F; Carlier T; Bodet-Milin C
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28036044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
    Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
    Jauw YW; Menke-van der Houven van Oordt CW; Hoekstra OS; Hendrikse NH; Vugts DJ; Zijlstra JM; Huisman MC; van Dongen GA
    Front Pharmacol; 2016; 7():131. PubMed ID: 27252651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunodetection and therapy of breast cancer.
    DeNardo SJ
    Semin Nucl Med; 2005 Apr; 35(2):143-51. PubMed ID: 15765377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer imaging with radiolabeled antibodies: new advances with technetium-99m-labeled monoclonal antibody Fab' fragments, especially CEA-Scan and prospects for therapy.
    Goldenberg DM; Juweid M; Dunn RM; Sharkey RM
    J Nucl Med Technol; 1997 Mar; 25(1):18-23; quiz 34. PubMed ID: 9239599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunodetection and radioimmunotherapy of head and neck cancer.
    Börjesson PK; Postema EJ; de Bree R; Roos JC; Leemans CR; Kairemo KJ; van Dongen GA
    Oral Oncol; 2004 Sep; 40(8):761-72. PubMed ID: 15288829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Immuno-PET in Antibody-Drug Conjugate Development.
    Carmon KS; Azhdarinia A
    Mol Imaging; 2018; 17():1536012118801223. PubMed ID: 30370812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats.
    Brouwers A; Verel I; Van Eerd J; Visser G; Steffens M; Oosterwijk E; Corstens F; Oyen W; Van Dongen G; Boerman O
    Cancer Biother Radiopharm; 2004 Apr; 19(2):155-63. PubMed ID: 15186595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing the magic bullet? The advancement of immuno-PET into clinical use.
    Wright BD; Lapi SE
    J Nucl Med; 2013 Aug; 54(8):1171-4. PubMed ID: 23908265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiochemistry, Production Processes, Labeling Methods, and ImmunoPET Imaging Pharmaceuticals of Iodine-124.
    Kumar K; Ghosh A
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33466827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies.
    Malviya G; Conti F; Chianelli M; Scopinaro F; Dierckx RA; Signore A
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):386-98. PubMed ID: 19777175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody positron emission tomography imaging in anticancer drug development.
    Lamberts LE; Williams SP; Terwisscha van Scheltinga AG; Lub-de Hooge MN; Schröder CP; Gietema JA; Brouwers AH; de Vries EG
    J Clin Oncol; 2015 May; 33(13):1491-504. PubMed ID: 25779566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.